Essa Pharma Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview

ESSA Pharma

02/02/2024 12:03

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on February 5
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for ESSA Pharma Inc is for a
loss
of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $17.50​, above​ its last closing price of $8.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023              -0.21      -0.12     Beat    42.9
 Jun. 30 2023  -0.19       -0.19      -0.17     Beat    12.8
 Mar. 31 2023  -0.20       -0.20      -0.16     Beat    22​
 Dec. 31 2022  -0.22       -0.23      -0.15     Beat    36.2
 ​​Sep.                    -0.27      -0.14     Beat    49.1
 30 2022                                                
 Jun. 30 2022  -0.28       -0.27      -0.20     Beat    25.9​
 Mar. 31 2022  -0.26       -0.25      -0.25     Met     1
 Dec. 31 2021  -0.23       -0.23      -0.21     Beat    8.7
 This summary was machine generated February 2 at 12:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)